PERCEPTIVE ADVISORS LLC 13D and 13G filings for Verrica Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:15 pm Sale |
2024-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 4,731,150 5.100% |
-3,230,997 (-40.58%) |
Filing |
| 2024-12-09 6:22 pm Purchase |
2024-12-05 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 7,962,147 8.700% |
862,965 (+12.16%) |
Filing |
| 2024-02-14 4:47 pm Purchase |
2023-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 7,099,182 16.900% |
2,060,199 (+40.89%) |
Filing |
| 2023-02-14 2:37 pm Purchase |
2022-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 5,038,983 12.300% |
1,428,571 (+39.57%) |
Filing |
| 2022-02-14 3:54 pm Purchase |
2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 3,610,412 13.100% |
200,000 (+5.86%) |
Filing |
| 2021-02-16 8:57 pm Purchase |
2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 3,410,412 13.200% |
3,410,412 (New Position) |
Filing |
| 2021-02-16 3:47 pm Sale |
2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-3,410,412 (Position Closed) |
Filing |